AD patients with TDP-43 pathology show worse cognitive impairment, but how TDP-43 mechanistically contributes to this severity is unknown. Understanding this could identify TDP-43 as a therapeutic target for cognitive preservation in AD. Gap type: unexplained_observation Source paper: TDP-43 Pathology in Alzheimer's Disease. (2021, Mol Neurodegener, PMID:34930382)
Landscape Summary: What mechanisms underlie TDP-43's contribution to cognitive impairment severity in AD patients? is a 0.78 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
What mechanisms underlie TDP-43's contribution to cognitive impairment severity in AD patients? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: